Market Cap (In USD)
6447.00
Revenue (In USD)
6.07 Million
Net Income (In USD)
-13.77 Million
Avg. Volume
456.23 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-4-0.0045
- PE
- -
- EPS
- -
- Beta Value
- 1.097
- ISIN
- US0948571098
- CUSIP
- 094857109
- CIK
- 1138608
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Michael Hill
- Employee Count
- -
- Website
- https://www.bloomios.com
- Ipo Date
- 2003-04-22
- Details
- Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
More Stocks
-
SPS
-
LIXTW
-
SY
-
FRASFrasers Group plc
FRAS
-
NITINCASTNitin Castings Limited
NITINCAST
-
LICI
-
DPAM
-
DUROPLYDUROPLY INDUSTRIES LIMITED
DUROPLY